With shrinking farmland due to urban expansion and the declining performance of traditional seeds, scientists and growers ...

"Its return represents both ecological restoration and spiritual renewal." 'De-extinction' company announces plan to ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

Anshu Sharma, Ph D Scholar, School of Biotechnology, Shri Mata Vaishno Devi University (SMVDU), presented poster entitled ...

Colorado Bureau of Investigation (CBI) is conducting a homicide investigation in Center after a 78-year-old man was found ...

Algaven PhycoGen Private Limited is rapidly emerging as one of India's most dynamic biotechnology and green innovation enterprises, redefining the intersection of science, sustainability, and ...

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

KKR's 2026 Outlook finds value beyond the S&P 500. Explore investment strategies in Asia, biotech, and critical infrastructure.

Aligned with Elecosoft’s established U.S. operations, PEMAC continues to deliver trusted CMMS and reliability software that ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

The FDA is being transformed from an independent regulator into a high-stakes bargaining chip for White House deal-making.

Focused on precision oncology and rare genetic diseases, this biotech reported a significant insider sale amid strong one-year stock gains.